ArticlePloS one2026
Neuropeptide visualization using split GFP in live C. elegans.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Neuropeptides play essential roles as signaling molecules in the nervous system of animals. Visualization of neuropeptides in experimental settings has advanced through two main approaches: using antibody-based methods and fluorescent protein tagging. These conventional approaches have inherent drawbacks, such as poor antibody specificity and potential functional perturbations due to fusion with bulky, full-length fluorescent proteins. The split GFP system is a versatile tool with broad applications, yet it has been underutilized for neuropeptide labeling. We demonstrate the utility of the split GFP system in the in vivo visualization of two neuropeptides, INS-1 and NLP-40, released from and targeted to neuronal and non-neuronal cells and tissues in C. elegans. Released neuropeptides were successfully visualized by inserting the 16-amino acid GFP11 tag to the sequence of neuropeptides of interest and complementing it with extracellular GFP1-10 fused to a membrane anchor protein, CD4. We show that fusion with the GFP11 tag does not perturb INS-1 function. Furthermore, we explore the in vivo regulation of neuropeptide release using genetic approaches. Our findings uncover a new application of the split GFP system which offers advantages over conventional methods for labeling neuropeptides and new insights into the regulation of neuropeptide secretion.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.